Structural studies of human purine nucleoside phosphorylase: Towards a new specific empirical scoring function

被引:28
作者
Saraiva Macedo Timmers, Luis Fernando [2 ]
Caceres, Rafael Andrade [2 ,3 ]
Vivan, Ana Luiza [2 ]
Gava, Lisandra Marques [4 ]
Dias, Raquel [2 ]
Ducati, Rodrigo Gay [1 ,5 ]
Basso, Luiz Augusto [1 ,3 ]
Santos, Diogenes Santiago [1 ,3 ]
de Azevedo, Walter Filgueira, Jr. [2 ,3 ]
机构
[1] Pontificia Univ Catolica Rio Grande do Sul, Ctr Pesquisas Biol Mol & Func, Inst Pesquisas Biomed, BR-90619900 Porto Alegre, RS, Brazil
[2] Pontificia Univ Catolica Rio Grande do Sul, Lab Bioquim Estrutural, Fac Biociencias, Porto Alegre, RS, Brazil
[3] Pontificia Univ Catolica Rio Grande do Sul, Programa Posgrad Med & Ciencias Saude, Porto Alegre, RS, Brazil
[4] Univ Estadual Campinas, Campinas, SP, Brazil
[5] Univ Fed Rio Grande do Sul, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil
关键词
Empirical scoring functions; Docking; Virtual screening; Quinazolinone; Enzymology; Molecular dynamics;
D O I
10.1016/j.abb.2008.08.015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human purine nucleoside phosphorylase (HsPNP) is a target for inhibitor development aiming at T-cell immune response modulation. In this work, we report the development of a new set of empirical scoring functions and its application to evaluate binding affinities and docking results. To test these new functions, we solved the structure of HsPNP and 2-mercapto-4(3H)-quinazolinone (HsPNP:MQU) binary complex at 2.7 A resolution using synchrotron radiation, and used these functions to predict ligand position obtained in Clocking Simulations. We also employed molecular dynamics simulations to analyze HsPNP in two conditions, as apoenzyme and in the binary complex form, in order to assess the structural features responsible for stability. Analysis of the Structural differences between systems provides explanation for inhibitor binding. The use of these scoring functions to evaluate binding affinities and molecular docking results may be used to guide future efforts on virtual screening focused on HsPNP. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:28 / 38
页数:11
相关论文
共 65 条
[1]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[2]   In vivo and in vitro pharmacologic activity of the purine nucleoside phosphorylase inhibitor BCX-34: The role of GTP and dGTP [J].
Bantia, S ;
Montgomery, JA ;
Johnson, HG ;
Walsh, GM .
IMMUNOPHARMACOLOGY, 1996, 35 (01) :53-63
[3]  
BERENDSEN HJC, 1998, INTERMOLECULAR FORCE, P331
[4]  
Bohm H. J., 2003, PROTEIN LIGAND INTER, P3, DOI 10.1002/3527601813
[5]  
Bohm HJ, 1996, ANGEW CHEM INT EDIT, V35, P2589
[6]  
BOURNE PE, 2003, STRUCTURAL BIOINFORM, P448
[7]   Purine nucleoside phosphorylases: properties, functions, and clinical aspects [J].
Bzowska, A ;
Kulikowska, E ;
Shugar, D .
PHARMACOLOGY & THERAPEUTICS, 2000, 88 (03) :349-425
[8]   Molecular modeling and dynamics simulations of PNP from Streptococcus agalactiae [J].
Caceres, Rafael Andrade ;
Saraiva Timmers, Luis Fernando ;
Dias, Raquel ;
Basso, Luiz Augusto ;
Santos, Diogenes Santiago ;
de Azevedo, Walter Filgueira, Jr. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (09) :4984-4993
[9]   New catalytic mechanism for human purine nucleoside phosphorylase [J].
Canduri, F ;
Fadel, V ;
Basso, LA ;
Palma, MS ;
Santos, DS ;
de Azevedo, WF .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 327 (03) :646-649
[10]   Crystal structure of human PNP complexed with hypoxanthine and sulfate ion [J].
Canduri, F ;
Fadel, V ;
Dias, MVB ;
Basso, LA ;
Palma, MS ;
Santos, DS ;
de Azevedo, WF .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 326 (02) :335-338